These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6891621)

  • 41. Hyperacute allergic encephalomyelitis: adjuvant effect of pertussis vaccines and extracts.
    Levine S; Wenk EJ; Devlin HB; Pieroni RE; Levine L
    J Immunol; 1966 Sep; 97(3):363-8. PubMed ID: 5332650
    [No Abstract]   [Full Text] [Related]  

  • 42. Immunomodulation of murine experimental autoimmune encephalomyelitis by pertussis toxin: the protective activity, but not the disease-enhancing activity, can be attributed to the nontoxic B-oligomer.
    Ben-Nun A; Mendel I; Kerlero de Rosbo N
    Proc Assoc Am Physicians; 1997 Mar; 109(2):120-5. PubMed ID: 9069580
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and safety of new adjuvants.
    Aucouturier J; Ganne V; Laval A
    Ann N Y Acad Sci; 2000; 916():600-4. PubMed ID: 11193681
    [No Abstract]   [Full Text] [Related]  

  • 44. Analysis of the role of Bphs/Hrh1 in the genetic control of responsiveness to pertussis toxin.
    Gao JF; Call SB; Fillmore PD; Watanabe T; Meeker ND; Teuscher C
    Infect Immun; 2003 Mar; 71(3):1281-7. PubMed ID: 12595443
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel vaccine formulations against pertussis offer earlier onset of immunity and provide protection in the presence of maternal antibodies.
    Polewicz M; Gracia A; Garlapati S; van Kessel J; Strom S; Halperin SA; Hancock RE; Potter AA; Babiuk LA; Gerdts V
    Vaccine; 2013 Jun; 31(31):3148-55. PubMed ID: 23684829
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Experimental allergic encephalomyelitis in inbred and outbred mice.
    Levine S; Sowinski R
    J Immunol; 1973 Jan; 110(1):139-43. PubMed ID: 4631068
    [No Abstract]   [Full Text] [Related]  

  • 47. [Action of Bordetella pertussis vaccine on mouse hematopoietic stem cells].
    Khorobrykh VV; Barteneva NS; Sanin AV; Snegireva AE
    Biull Eksp Biol Med; 1982 Jun; 93(6):107-10. PubMed ID: 7115919
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Improved pertussis vaccines based on adjuvants that induce cell-mediated immunity.
    Allen AC; Mills KH
    Expert Rev Vaccines; 2014 Oct; 13(10):1253-64. PubMed ID: 25017925
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pertactin deficient Bordetella pertussis present a better fitness in mice immunized with an acellular pertussis vaccine.
    Hegerle N; Dore G; Guiso N
    Vaccine; 2014 Nov; 32(49):6597-600. PubMed ID: 25312274
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Induction of inhibitory central nervous system-derived and stimulatory blood-derived dendritic cells suggests a dual role for granulocyte-macrophage colony-stimulating factor in central nervous system inflammation.
    Hesske L; Vincenzetti C; Heikenwalder M; Prinz M; Reith W; Fontana A; Suter T
    Brain; 2010 Jun; 133(Pt 6):1637-54. PubMed ID: 20424288
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A new murine model of autoimmune orchitis induced by immunization with viable syngeneic testicular germ cells alone. I. Immunological and histological studies.
    Itoh M; Hiramine C; Hojo K
    Clin Exp Immunol; 1991 Jan; 83(1):137-42. PubMed ID: 1988220
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Autoimmune cell-mediated responses: spontaneous responses to syngeneic cells in NZB/NZW F1 mice.
    Senitzer D; Cafruny W; Raeder R; Freimer EH
    J Immunol; 1979 Aug; 123(2):660-6. PubMed ID: 458154
    [No Abstract]   [Full Text] [Related]  

  • 53. Inhaled Bordetella pertussis vaccine decreases airway responsiveness in guinea pigs.
    Vargas MH; Bazán-Perkins B; Segura P; Campos MG; Selman M; Montaño LM
    Life Sci; 1995; 57(19):PL293-9. PubMed ID: 7475913
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A unitarian hypothesis of altered reactivity to stress mediated by Bordetella pertussis.
    Levine L; Pieroni RE
    Experientia; 1966 Dec; 22(12):797-8. PubMed ID: 5973213
    [No Abstract]   [Full Text] [Related]  

  • 55. INDUCTION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS IN RATS WITHOUT THE AID OF ADJUVANT.
    LEVINE S; WENK EJ
    Ann N Y Acad Sci; 1965 Mar; 122():209-26. PubMed ID: 14313479
    [No Abstract]   [Full Text] [Related]  

  • 56. Carbonyl iron: a new adjuvant for experimental autoimmune diseases.
    Levine S; Sowinski R
    J Immunol; 1970 Dec; 105(6):1530-5. PubMed ID: 5483831
    [No Abstract]   [Full Text] [Related]  

  • 57. Allergic encephalomyelitis: rapid induction without the aid of adjuvants.
    LEVINE S; WENK EJ
    Science; 1963 Aug; 141(3580):529-30. PubMed ID: 13930176
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Durability of immune protection against experimental autoimmune encephalomyelitis.
    Bernard CC; Mackay IR; Whittingham S; Brous P
    Cell Immunol; 1976 Mar; 22(2):297-310. PubMed ID: 58731
    [No Abstract]   [Full Text] [Related]  

  • 59. Immunomodulation by Bordetella pertussis: antiviral effects.
    Winters AL; Baggett DW; Lee JD; Sloan GL; Lemmon RD; Stinson RS
    Dev Biol Stand; 1985; 61():233-40. PubMed ID: 2872109
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Optimization of immunization schedule to standardize antibody response in mice to pertussis vaccines.
    Tiru M; Jäätmaa E; Gillenius P; Askelöf P
    Dev Biol Stand; 1985; 61():469-75. PubMed ID: 2872128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.